Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
Cash from Financing Activities
Immuno-Biological Laboratories Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Cash from Financing Activities
¥992k
|
CAGR 3-Years
-80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-43%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Financing Activities
-¥1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Financing Activities
¥1.2B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
CellSource Co Ltd
TSE:4880
|
Cash from Financing Activities
¥1.4B
|
CAGR 3-Years
112%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Financing Activities
-¥101.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
See Also
What is Immuno-Biological Laboratories Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
992k
JPY
Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Cash from Financing Activities amounts to 992k JPY.
What is Immuno-Biological Laboratories Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-43%
Over the last year, the Cash from Financing Activities growth was -93%. The average annual Cash from Financing Activities growth rates for Immuno-Biological Laboratories Co Ltd have been -80% over the past three years , and -43% over the past ten years .